- Home
- ABVE vs IGC Comparison
ABVE vs IGC Comparison
Compare ABVE & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVE
- IGC
- Stock Information
- Founded
- ABVE 2019
- IGC 2005
- Country
- ABVE Canada
- IGC United States
- Employees
- ABVE N/A
- IGC N/A
- Industry
- ABVE Packaged Foods
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- ABVE Consumer Staples
- IGC Health Care
- Exchange
- ABVE Nasdaq
- IGC Nasdaq
- Market Cap
- ABVE 35.9M
- IGC 33.5M
- IPO Year
- ABVE N/A
- IGC N/A
- Fundamental
- Price
- ABVE $1.72
- IGC $0.34
- Analyst Decision
- ABVE
- IGC Strong Buy
- Analyst Count
- ABVE 0
- IGC 2
- Target Price
- ABVE N/A
- IGC $3.88
- AVG Volume (30 Days)
- ABVE 50.2M
- IGC 7.6M
- Earning Date
- ABVE 02-15-2025
- IGC 08-07-2025
- Dividend Yield
- ABVE N/A
- IGC N/A
- EPS Growth
- ABVE N/A
- IGC N/A
- EPS
- ABVE N/A
- IGC N/A
- Revenue
- ABVE $213,446,206.00
- IGC $1,271,000.00
- Revenue This Year
- ABVE N/A
- IGC $15.26
- Revenue Next Year
- ABVE N/A
- IGC $3.41
- P/E Ratio
- ABVE N/A
- IGC N/A
- Revenue Growth
- ABVE N/A
- IGC N/A
- 52 Week Low
- ABVE $0.25
- IGC $0.25
- 52 Week High
- ABVE $4.40
- IGC $0.48
- Technical
- Relative Strength Index (RSI)
- ABVE N/A
- IGC 47.01
- Support Level
- ABVE N/A
- IGC $0.35
- Resistance Level
- ABVE N/A
- IGC $0.39
- Average True Range (ATR)
- ABVE 0.00
- IGC 0.03
- MACD
- ABVE 0.00
- IGC -0.00
- Stochastic Oscillator
- ABVE 0.00
- IGC 23.78
About ABVE Above Food Ingredients Inc. Common Stock
Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.